Setmelanotide
98%
- Product Code: 109594
CAS:
920014-72-8
| Molecular Weight: | 1117.31 g./mol | Molecular Formula: | C₄₉H₆₈N₁₈O₉S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Setmelanotide is primarily used in the treatment of specific genetic disorders related to obesity. It is particularly effective for patients with pro-opiomelanocortin (POMC) deficiency, leptin receptor (LEPR) deficiency, or Bardet-Biedl syndrome. The medication works by activating melanocortin-4 receptors in the brain, which helps regulate hunger, energy expenditure, and body weight. This leads to reduced appetite and significant weight loss in affected individuals. It is administered as a subcutaneous injection and is often prescribed when other weight management strategies have failed. Setmelanotide offers a targeted approach for these rare conditions, improving quality of life and addressing the underlying causes of obesity in these patients.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿40,824.00 |
+
-
|
Setmelanotide
Setmelanotide is primarily used in the treatment of specific genetic disorders related to obesity. It is particularly effective for patients with pro-opiomelanocortin (POMC) deficiency, leptin receptor (LEPR) deficiency, or Bardet-Biedl syndrome. The medication works by activating melanocortin-4 receptors in the brain, which helps regulate hunger, energy expenditure, and body weight. This leads to reduced appetite and significant weight loss in affected individuals. It is administered as a subcutaneous injection and is often prescribed when other weight management strategies have failed. Setmelanotide offers a targeted approach for these rare conditions, improving quality of life and addressing the underlying causes of obesity in these patients.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :